Here's the live share price of Sandu Pharmaceuticals along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Source: Dion Global
Source: Dion Global
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Sandu Pharmaceuticals | 0.52 | -3.52 | -9.65 | 10.34 | -20 | -12.48 | -4.93 |
| Sun Pharmaceutical Industries | -1.06 | -2.52 | 6.52 | 6.56 | 19.13 | 18.83 | 19.37 |
| Divi's Laboratories | 0.39 | 11.44 | 40.48 | 46.22 | 54.84 | 36.71 | 12.32 |
| Torrent Pharmaceuticals | -2.42 | -1.7 | 11.19 | 12.86 | 37.24 | 37.92 | 25.7 |
| Zydus Lifesciences | -2.7 | 3.96 | 6.07 | 26.31 | 13.89 | 22.15 | 15.71 |
| Cipla | -1.56 | -3.73 | -0.34 | 5.28 | -10.13 | 4.07 | 7.99 |
| Laurus Labs | -3.46 | 1.39 | 29.11 | 78.63 | 112.05 | 66.28 | 23.12 |
| Aurobindo Pharma | 0.48 | 2.76 | 13.36 | 35.26 | 58.75 | 24.79 | 17.03 |
| Lupin | -3.22 | -11.78 | -7.19 | -9.75 | 8.25 | 23.44 | 16.46 |
| Mankind Pharma | -2.74 | -5.3 | -0.64 | 4.34 | -8.99 | 9.46 | 10.27 |
| Dr. Reddy's Laboratories | -2.78 | -2.47 | -10.39 | -12.8 | -9.74 | 0.87 | 3.1 |
| Glenmark Pharmaceuticals | -2.2 | 9.52 | 13.69 | 16.67 | 19.89 | 45.83 | 35.65 |
| Biocon | -4.35 | -7.41 | -4.5 | 1.78 | 8.16 | 13.79 | 1.72 |
| Alkem Laboratories | -3.18 | -8.53 | -1.36 | -6.57 | -2.93 | 12.41 | 6.25 |
| Abbott India | -1.88 | -6.97 | -0.84 | -6.51 | -17.25 | 4.21 | 5.63 |
| Anthem Biosciences | 3.71 | 13.11 | 22.58 | 40.17 | 12.56 | 8.54 | 5.04 |
| GlaxoSmithKline Pharmaceuticals | -4.38 | 15.72 | 37.1 | 19.85 | 7.21 | 26.82 | 14.65 |
| Ipca Laboratories | 0.53 | 10.99 | 19.35 | 30.75 | 46.87 | 30.02 | 9.44 |
| Gland Pharma | 2.98 | 16.75 | 30.8 | 74.32 | 56.96 | 20.62 | -5.73 |
| Ajanta Pharma | -1.51 | 1.94 | 17.72 | 17.85 | 34.16 | 27.05 | 18.91 |
Source: Dion Global
Over the last one year, Sandu Pharmaceuticals has declined 20.00% compared to peers like Sun Pharmaceutical Industries (19.13%), Divi's Laboratories (54.84%), Torrent Pharmaceuticals (37.24%). From a 5 year perspective, Sandu Pharmaceuticals has underperformed peers relative to Sun Pharmaceutical Industries (19.37%) and Divi's Laboratories (12.32%).
Source: Dion Global
| Day | SMA | EMA |
|---|---|---|
| 5 | 38.29 | 38.3 |
| 10 | 37.93 | 38.14 |
| 20 | 38.01 | 38.26 |
| 50 | 39.33 | 38.99 |
| 100 | 40.33 | 39.33 |
| 200 | 38.49 | 40.41 |
Source: Dion Global
In the latest quarter, Sandu Pharmaceuticals remained same as its previous close in promoter holding, while DII stake unchanged at 0.01%, FII holding unchanged at 0.00%, and public shareholding unchanged at 62.20% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Date Time | Announcement |
|---|---|
| Aug 19, 2026, 11:12 PM IST IST | Sandu Pharma. - Announcement Under Regulation 30-Letter To Shareholder On Annual Report Weblink Whose Email Ids Are Not Regis |
| Aug 19, 2026, 11:09 PM IST IST | Sandu Pharma. - Reg. 34 (1) Annual Report. |
| Aug 19, 2026, 11:03 PM IST IST | Sandu Pharma. - Annual General Meeting To Be Held On 11Th September 2026 At 04:30 Pm Through Video Conferencing ('VC')/ Othe |
| Aug 12, 2026, 12:12 AM IST IST | Sandu Pharma. - Approval Of Material Related Party Transactions Subject To Approval Of Shareholders |
| Aug 12, 2026, 12:09 AM IST IST | Sandu Pharma. - Statement Of Deviation And Utilisation Of Funds For Q Ended 30.06.2026 |
Source: Dion Global
Sandu Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 15/11/1985 and has its registered office in the State of Goa, India. Company's Corporate Identification Number(CIN) is L24233GA1985PLC001587 and registration number is 001587. Currently Company is involved in the business activities of Manufacture of `ayurvedic' or `unani' pharmaceutical preparation. Company's Total Operating Revenue is Rs. 69.93 Cr. and Equity Capital is Rs. 9.66 Cr. for the Year ended 31/03/2026.
Source: Dion Global
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Sandu Pharmaceuticals is ₹38.40 as on Sep 07, 2026.
The Sandu Pharmaceuticals is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Sandu Pharmaceuticals is ₹37.10 Cr as on Sep 07, 2026.
Today’s highest and lowest price of Sandu Pharmaceuticals are ₹39.00 and ₹36.43.
The 52-week high/low is the highest and lowest price at which Sandu Pharmaceuticals stock has traded in the past 52-week or nearly a year. The 52-week high of Sandu Pharmaceuticals is ₹50.50 and 52-week low of Sandu Pharmaceuticals is ₹30.00 as on Sep 07, 2026.
The Sandu Pharmaceuticals has shown returns of 0.47% over the past day, -3.52% for the past month, -9.65% over 3 months, -20.0% over 1 year, -12.48% across 3 years, and -4.93% over 5 years.
P/E ratio of and PB ratio of Sandu Pharmaceuticals are 23.91 and 0.91 on Sep 07, 2026. While the company gives a dividend yield of 2.60 per annum.
Source: Dion Global